LYEL Competitors & Alternatives
Compare Lyell Immunopharma Inc with similar stocks in the same industry
Biotechnology
LYEL
Main Stock$13.40
Tradestie Score
51
Market Cap
$317.95M
Revenue Growth
-0.7%
Analyst Upside
+177.4%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CAPR
Capricor Therapeutics Inc
|
$20.68
|
$357.51M | - | 49 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.77
|
$354.45M | - | 58 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$32.02
|
$353.70M | - | 57 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.93
|
$341.56M | - | 55 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.55
|
$332.96M | - | 64 | Compare |
|
REPL
Replimune Group, Inc.
|
$9.87
|
$328.62M | - | 55 | Compare |
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.16
|
$319.22M | - | 54 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.57
|
$308.74M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.87
|
$304.12M | - | 52 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.34
|
$297.23M | - | 59 | Compare |
More LYEL Analysis
Data updated: Jul 15, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry